XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.
Desktop mode

Publications 2016

  • Our strategy 2017-2021

    | 15 December 2016 |

    The Danish Medicines Agency: Among Europe's best in class! This is the title of our strategy for 2017-2021, which emphasises our commitment to both public health and growth in Denmark.

  • Clinical trials of medicines - Annual report 2015

    | 09 August 2016 |

    Last year, the Danish Medicines Agency received 329 applications for authorisation of clinical trials of medicines in humans – 45 applications more than in 2014. The figures appear from the Danish Medicines Agency’s annual report on clinical trials.

  • Annual pharmacovigilance report 2015

    | 25 April 2016 |

    Openness and dialogue are keywords in the Danish Medicines Agency's work with adverse reactions. In 2015, this was to become particularly important. Since 2009, almost 2,000 girls and young women had reported suspected adverse reactions to the Gardasil® HPV vaccine, and patient organisations and the media wanted us to join the debate.

Did you get answers to your questions?

Please tell us how we can improve our website?